ITMCTR2000004129尚未招募1 期
A clinical study on the treatment of generalized anxiety disorder with the
West China Hospital, Sichuan University0 个研究点开始时间: 待定最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 18 至 75（—）
- 性别
- All
入选标准
- •1. MEET the diagnostic criteria of GAD in CCMD-3;
- •2. The age should be 18-75 years old;
- •3. Hamilton Anxiety Scale (HAMA) score >=14;
- •4. Patients who receive and adhere to western medicine or acupuncture treatment;
- •5. Sign the informed consent.
排除标准
- •1. Secondary anxiety of somatic diseases, drug withdrawal reaction, and secondary anxiety of other mental diseases;
- •2. Pregnant and lactating women with severe cardiopulmonary, liver and kidney dysfunction;
- •3. History of organic brain disease and serious mental illness;
- •4. Those who are receiving systematic psychological treatment;
- •5. Those who have failed to respond to previous treatment with paroxetine or are allergic;
- •6. There is inflammation, scar or trauma at the site of operation, or other severe systemic infection.
研究者
相似试验
招募中
不适用
Investigation of clinical course and treatment of acute exacerbation of interstitial lung disease - A Prospective Observational StudyJPRN-UMIN000043154Hamamatsu University School of Medicine400
尚未招募
1 期
A multi-center clinical study on the treatment of knee osteoarthritis with Qubi Yangge Decoction combined with three steps and nine methods of whole kneeknee osteoarthritisITMCTR2000003608onghua Hospital, Shanghai University of Traditional Chinese Medicine
尚未招募
Unknown
A study on fever using therapeutics of fever by H C AlleCTRI/2024/03/063748Sarada Krishna Homoeopathic medical college
招募中
Unknown
Clinical observation on the treatment of moderate female stress urinary incontinence with optimized formula of Qishi granules based on the theory of spleen kidney correlatioFemale stress urinary incontinenceITMCTR2024000008Xiyuan Hospital, China Academy of Chinese Medical Sciences
招募中
不适用
Clinico-pathological study on the effectiveness of cepharanthin on the prevention of destruction of acinar structure in Sjogren's syndrome patientss syndromeSjogren's syndromeJPRN-UMIN000005878Department of Oral Medicine, Institute of Health Biosciences, The University of Tokushima Graduate Faculty of Dentistry10